Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4604

1.

Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys.

Park SJ, Kim J, Kim SN, Lee EJ, Oh S, Seol A, Lee N, Chang SJ, Kim HS.

Jpn J Clin Oncol. 2018 Dec 6. doi: 10.1093/jjco/hyy175. [Epub ahead of print]

PMID:
30521037
2.

What is the appropriate communication style for family members confronting difficult surrogate decision-making in palliative care?: A randomized video vignette study in medical staff with working experiences of clinical oncology.

Nishioka M, Okuyama T, Uchida M, Aiki S, Ito Y, Osaga S, Imai F, Akechi T.

Jpn J Clin Oncol. 2018 Dec 1. doi: 10.1093/jjco/hyy178. [Epub ahead of print]

PMID:
30508206
3.

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.

Ohe Y, Imamura F, Nogami N, Okamoto I, Kurata T, Kato T, Sugawara S, Ramalingam SS, Uchida H, Hodge R, Vowler SL, Walding A, Nakagawa K.

Jpn J Clin Oncol. 2018 Dec 1. doi: 10.1093/jjco/hyy179. [Epub ahead of print]

PMID:
30508196
4.

Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.

Kashiwada T, Saito Y, Terasaki Y, Hisakane K, Takeuchi S, Sugano T, Miyanaga A, Noro R, Minegishi Y, Seike M, Kubota K, Gemma A.

Jpn J Clin Oncol. 2018 Dec 1. doi: 10.1093/jjco/hyy180. [Epub ahead of print]

PMID:
30508192
5.

Co-operative groups in the development of chemotherapy for gastric cancer.

Arai H, Sunakawa Y, Nakajima TE.

Jpn J Clin Oncol. 2018 Dec 1. doi: 10.1093/jjco/hyy176. [Epub ahead of print]

PMID:
30508188
6.

Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.

Lai J, Pan Z, Chen P, Ye G, Chen K, Su F.

Jpn J Clin Oncol. 2018 Dec 1. doi: 10.1093/jjco/hyy181. [Epub ahead of print]

PMID:
30508184
7.

Thanking All Peer Reviewers.

[No authors listed]

Jpn J Clin Oncol. 2018 Dec 1;48(12):1031-1033. doi: 10.1093/jjco/hyy169. No abstract available.

PMID:
30476273
8.

JJCO Paper of the Year and Highly Commended Paper.

[No authors listed]

Jpn J Clin Oncol. 2018 Dec 1;48(12):1034. doi: 10.1093/jjco/hyy168. No abstract available.

PMID:
30476272
9.

JJCO Best Reviewer Award.

[No authors listed]

Jpn J Clin Oncol. 2018 Dec 1;48(12):1035. doi: 10.1093/jjco/hyy167. No abstract available.

PMID:
30476271
10.

Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study.

Shirotake S, Makino S, Suzuki K, Araki R, Kosaka T, Nishimoto K, Oyama M, Kato S.

Jpn J Clin Oncol. 2018 Nov 23. doi: 10.1093/jjco/hyy174. [Epub ahead of print]

PMID:
30476164
11.

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice.

Park SS, Eom HS, Kim JS, Koh Y, Choi CW, Lee JJ, Kim K, Suh C, Lee JH, Min CK; Korean Multiple Myeloma Working Party.

Jpn J Clin Oncol. 2018 Nov 23. doi: 10.1093/jjco/hyy177. [Epub ahead of print]

PMID:
30476124
12.

Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives.

Taguchi S, Fukuhara H, Todo T.

Jpn J Clin Oncol. 2018 Nov 20. doi: 10.1093/jjco/hyy170. [Epub ahead of print]

PMID:
30462296
13.

Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.

Yoh K, Takamochi K, Shukuya T, Hishida T, Tsuboi M, Sakurai H, Goto Y, Yoshida K, Ohde Y, Okumura S, Ohashi Y, Kunitoh H.

Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy165. [Epub ahead of print]

PMID:
30452719
14.

Radiation-induced dermatitis after administration of mogamulizumab for adult T-cell leukaemia/lymphoma: a multi-institutional retrospective study.

Maemoto H, Ariga T, Kusada T, Heianna J, Manabe Y, Miyakawa A, Nakachi S, Morishima S, Iraha S, Ganaha F, Masuzaki H, Murayama S.

Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy172. [Epub ahead of print]

PMID:
30452692
15.

Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer.

Miyamoto S, Nomura R, Sato K, Awano N, Kuse N, Inomata M, Izumo T, Terada Y, Furuhata Y, Bae Y, Kunitoh H.

Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy171. [Epub ahead of print]

PMID:
30452687
16.

Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma.

Dracham CB, Mahajan R, Rai B, Elangovan A, Bhattacharya T, Ghoshal S.

Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy164. [Epub ahead of print]

PMID:
30452664
17.

Loss of psoas major muscle volume during systemic chemotherapy is related to worse prognosis in testicular cancer.

Mitsui Y, Sadahira T, Araki M, Maruyama Y, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.

Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy166. [Epub ahead of print]

PMID:
30452662
18.

A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.

Nozaki M, Kagami Y, Shibata T, Nakamura K, Ito Y, Nishimura Y, Kawaguchi Y, Saito Y, Nagata Y, Matsumoto Y, Akimoto T, Hiraoka M; Radiation Therapy Study Group, Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2018 Nov 14. doi: 10.1093/jjco/hyy160. [Epub ahead of print]

PMID:
30428042
19.

New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.

Tanaka K, Ozaki T.

Jpn J Clin Oncol. 2018 Nov 13. doi: 10.1093/jjco/hyy157. [Epub ahead of print]

PMID:
30423153
20.

Molecular-targeted therapies and precision medicine for endometrial cancer.

Mitamura T, Dong P, Ihira K, Kudo M, Watari H.

Jpn J Clin Oncol. 2018 Nov 13. doi: 10.1093/jjco/hyy159. [Epub ahead of print]

PMID:
30423148

Supplemental Content

Loading ...
Support Center